Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer”
Dose Dense TC + Pegfilgrastim Support for Breast Cancer
ClinicalTrials.gov study NCT01671319. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer
ClinicalTrials.gov study NCT01818063. IPD Sharing: Not stated. Countries: 1. Publications: 39.
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT03778931. IPD Sharing: YES. Countries: 17. Publications: 3.
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours
ClinicalTrials.gov study NCT01432145. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT02673398. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer
ClinicalTrials.gov study NCT01861054. IPD Sharing: NO. Countries: 1. Publications: 2.
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT02445391. IPD Sharing: YES. Countries: 2. Publications: 2.
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT03018080. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
ClinicalTrials.gov study NCT02595905. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment
ClinicalTrials.gov study NCT00121992. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
ClinicalTrials.gov study NCT00436566. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer
ClinicalTrials.gov study NCT00394251. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT03774472. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT01463072. IPD Sharing: NO. Countries: 1. Publications: 1.
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
ClinicalTrials.gov study NCT03483012. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
ClinicalTrials.gov study NCT01151215. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
ClinicalTrials.gov study NCT00553410. IPD Sharing: Not stated. Countries: 20. Publications: 2.
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
ClinicalTrials.gov study NCT00041119. IPD Sharing: Not stated. Countries: 2. Publications: 4.
BAY43-9006 - Phase II in Advanced Breast Cancer
ClinicalTrials.gov study NCT00101400. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
ClinicalTrials.gov study NCT00570921. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.